Spots Global Cancer Trial Database for Registry Study for Talimogene Laherparepvec
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Registry Study for Talimogene Laherparepvec
Official Title: A Registry Study to Evaluate the Survival and Long-Term Safety of Subjects Who Previously Received Talimogene Laherparepvec in Amgen or BioVEX-Sponsored Clinical Trials
Study ID: NCT02173171
Interventions
Study Description
Brief Summary: A Registry Study to Evaluate the Survival and Long-Term Safety of Subjects Who Previously Received Talimogene Laherparepvec in Amgen or BioVEX-Sponsored Clinical Trials
Detailed Description: A registry study is to evaluate the overall survival, use of subsequent anti-cancer therapy, and the long-term safety of subjects who have received at least one dose of talimogene laherparepvec on an Amgen or BioVEX-sponsored clinical trial for any tumor type. Follow-Up will occur every 3 months.
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
University of South Alabama Mitchell Cancer Institute, Mobile, Alabama, United States
University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States
St Joseph Heritage Healthcare, Santa Rosa, California, United States
University of Colorado Cancer Center, Aurora, Colorado, United States
Florida Hospital Memorial Division, Daytona Beach, Florida, United States
Baptist MD Anderson Cancer Center, Jacksonville, Florida, United States
Mount Sinai Comprehensive Cancer Center, Miami Beach, Florida, United States
H Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, United States
Oncology Specialists SC, Park Ridge, Illinois, United States
Investigative Clinical Research of Indiana, LLC, Indianapolis, Indiana, United States
Allina Health System dba Virginia Piper Cancer Institute, Minneapolis, Minnesota, United States
Saint Louis University Hospital, Saint Louis, Missouri, United States
Morristown Medical Center, Morristown, New Jersey, United States
Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, United States
University of North Carolina Chapel Hill, Chapel Hill, North Carolina, United States
Wake Forest Baptist Health Medical Center, Winston-Salem, North Carolina, United States
Gabrail Cancer Center, LLC, Canton, Ohio, United States
Providence Oncology and Hematology Care Eastside, Portland, Oregon, United States
Greenville Health System Institute for Translational Oncology Research, Greenville, South Carolina, United States
The West Clinic PC dba West Cancer Center, Germantown, Tennessee, United States
Henry Joyce Cancer Center, Nashville, Tennessee, United States
Mary Crowley Cancer Research, Dallas, Texas, United States
University of Texas MD Anderson Cancer Center, Houston, Texas, United States
Intermountain Medical Center, Murray, Utah, United States
University of Utah Huntsman Cancer Institute, Salt Lake City, Utah, United States
Wheaton Franciscan Healthcare, Franklin, Wisconsin, United States
Landeskrankenhaus Salzburg, Salzburg, , Austria
Universitaetsklinikum Allgemeines Krankenhaus Wien, Wien, , Austria
Tom Baker Cancer Centre, Calgary, Alberta, Canada
Cross Cancer Institute, Edmonton, Alberta, Canada
Princess Margaret Cancer Centre, Toronto, Ontario, Canada
Hopital Ambroise Pare, Boulogne Billancourt, , France
Centre Hospitalier Universitaire de Nantes, Hôpital Hôtel Dieu, Nantes Cedex 1, , France
University Hospital, Heidelberg, , Germany
Universitätsklinikum Tübingen, Tübingen, , Germany
General Hospital of Athens Laiko, Athens, , Greece
Metropolitan Hospital, Athens, , Greece
Bioclinic of Thessaloniki, Thessaloniki, , Greece
Pecsi Tudomanyegyetem Klinikai Kozpont, Pecs, , Hungary
Szegedi Tudomanyegyetem Szent-Gyorgyi Albert Klinikai Kozpont Altalanos Orvostudomanyi Kar, Szeged, , Hungary
Azienda Socio Sanitaria Territoriale Papa Giovanni XXIII, Bergamo, , Italy
IRCCS Istituto Europeo di Oncologia, Milano, , Italy
Azienda Ospedaliera Universitaria Senese Policlinico Le Scotte, Siena, , Italy
Yonsei University Health System Severance Hospital, Seoul, , Korea, Republic of
Narodowy Instytut Onkologii im Marii Sklodowskiej-Curie - Panstwowy Instytut Badawczy, Warszawa, , Poland
FSBI N N Blokhin Russian Oncology Research Center Ministry of Health of Russian Federation, Moscow, , Russian Federation
FSBI Scientific and Research Oncology Institute named after N N Petrov, Saint-Petersburg, , Russian Federation
Wilgers Oncology Centre, Pretoria, , South Africa
Hospital Clinic i Provincial de Barcelona, Barcelona, Cataluña, Spain
Hospital General Universitario de Valencia, Valencia, Comunidad Valenciana, Spain
Onkologikoa, San Sebastian, País Vasco, Spain
Hospital Universitario 12 de Octubre, Madrid, , Spain
Kantonsspital Graubuenden, Chur, , Switzerland
Hopitaux Universitaires de Geneve, Geneve, , Switzerland
Centre Hospitalier Universitaire Vaudois, Lausanne, , Switzerland
Universitaetsspital Zuerich, Zuerich Flughafen, , Switzerland
Guys and St Thomas Hospital, London, , United Kingdom
Royal Marsden Hospital, London, , United Kingdom
The Clatterbridge Cancer Centre NHS Foundation Trust, Wirral, , United Kingdom
Contact Details
Name: MD
Affiliation: Amgen
Role: STUDY_DIRECTOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
